290 related articles for article (PubMed ID: 34375916)
1. Neurology of the acute hepatic porphyrias.
Oliveira Santos M; Leal Rato M
J Neurol Sci; 2021 Sep; 428():117605. PubMed ID: 34375916
[TBL] [Abstract][Full Text] [Related]
2. Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.
Marcacci M; Ricci A; Cuoghi C; Marchini S; Pietrangelo A; Ventura P
Orphanet J Rare Dis; 2022 Apr; 17(1):160. PubMed ID: 35392955
[TBL] [Abstract][Full Text] [Related]
3. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
Wang B; Bonkovsky HL; Lim JK; Balwani M
Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
[TBL] [Abstract][Full Text] [Related]
4. Acute porphyrias - A neurological perspective.
Gerischer LM; Scheibe F; Nümann A; Köhnlein M; Stölzel U; Meisel A
Brain Behav; 2021 Nov; 11(11):e2389. PubMed ID: 34661997
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietic and hepatic porphyrias.
Gross U; Hoffmann GF; Doss MO
J Inherit Metab Dis; 2000 Nov; 23(7):641-61. PubMed ID: 11117426
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of acute attacks, chronic symptoms, and long-term complications among patients with acute hepatic porphyria in Japan: a real-world claims database study.
Horie Y; Yasuoka Y; Adachi T
Orphanet J Rare Dis; 2023 Dec; 18(1):384. PubMed ID: 38066651
[TBL] [Abstract][Full Text] [Related]
7. Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study.
Wang B; Ventura P; Takase KI; Thapar M; Cassiman D; Kubisch I; Liu S; Sweetser MT; Balwani M
Orphanet J Rare Dis; 2022 Aug; 17(1):327. PubMed ID: 36028858
[TBL] [Abstract][Full Text] [Related]
8. [Anesthesia in patients with acute porphyria].
Lederer D; Weigand MA; Larmann J
Anaesthesist; 2022 Apr; 71(4):321-330. PubMed ID: 35352131
[TBL] [Abstract][Full Text] [Related]
9. RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria.
Sardh E; Harper P
J Intern Med; 2022 May; 291(5):593-610. PubMed ID: 35067977
[TBL] [Abstract][Full Text] [Related]
10. Givosiran: A Review in Acute Hepatic Porphyria.
Syed YY
Drugs; 2021 May; 81(7):841-848. PubMed ID: 33871817
[TBL] [Abstract][Full Text] [Related]
11. [Acute hepatic porphyria and its neurological syndrome].
Bont A; Steck AJ; Meyer UA
Schweiz Med Wochenschr; 1996 Jan; 126(1-2):6-14. PubMed ID: 8571113
[TBL] [Abstract][Full Text] [Related]
12. Neurological Manifestations of Acute Porphyrias.
Wylie K; Testai FD
Curr Neurol Neurosci Rep; 2022 Jul; 22(7):355-362. PubMed ID: 35665475
[TBL] [Abstract][Full Text] [Related]
13. Givosiran to treat acute porphyria.
Honor A; Rudnick SR; Bonkovsky HL
Drugs Today (Barc); 2021 Jan; 57(1):47-59. PubMed ID: 33594389
[TBL] [Abstract][Full Text] [Related]
14. [Porphyrias].
Stölzel U; Stauch T; Doss MO
Internist (Berl); 2010 Dec; 51(12):1525-33; quiz 1534. PubMed ID: 21104216
[TBL] [Abstract][Full Text] [Related]
15. Acute Hepatic Porphyrias: "Purple Flags"-Clinical Features That Should Prompt Specific Diagnostic Testing.
Anderson KE; Desnick RJ; Stewart MF; Ventura P; Bonkovsky HL
Am J Med Sci; 2022 Jan; 363(1):1-10. PubMed ID: 34606756
[TBL] [Abstract][Full Text] [Related]
16. Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
Balwani M; Sardh E; Ventura P; Peiró PA; Rees DC; Stölzel U; Bissell DM; Bonkovsky HL; Windyga J; Anderson KE; Parker C; Silver SM; Keel SB; Wang JD; Stein PE; Harper P; Vassiliou D; Wang B; Phillips J; Ivanova A; Langendonk JG; Kauppinen R; Minder E; Horie Y; Penz C; Chen J; Liu S; Ko JJ; Sweetser MT; Garg P; Vaishnaw A; Kim JB; Simon AR; Gouya L;
N Engl J Med; 2020 Jun; 382(24):2289-2301. PubMed ID: 32521132
[TBL] [Abstract][Full Text] [Related]
17. Givosiran for the treatment of acute hepatic porphyria.
Ricci A; Ventura P
Expert Rev Clin Pharmacol; 2022 Apr; 15(4):383-393. PubMed ID: 35531651
[TBL] [Abstract][Full Text] [Related]
18. The acute hepatic porphyrias: current status and future challenges.
Siegesmund M; van Tuyll van Serooskerken AM; Poblete-Gutiérrez P; Frank J
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):593-605. PubMed ID: 20955962
[TBL] [Abstract][Full Text] [Related]
19. Novel treatment options for acute hepatic porphyrias.
Wang B
Curr Opin Gastroenterol; 2021 May; 37(3):194-199. PubMed ID: 33769375
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
